6,7-Dihydrothieno[3,2-c]pyridin-4(5H)-one, 97%, 5g

5-Bromo-2-chloro-(difluoromethoxy)benzene, 95.0%, 1g

Methyl 6-nitro-1H-indazole-4-carboxylate, 95.0%, 100mg

1-(Quinoxalin-6-yl)ethanone, 95.0%, 100mg

4-Methoxy-3,6-dihydro-2H-pyran, 95.0%, 250mg

2-hydrazinoquinazolin-4(3H)-one, 95.0%, 2.5g

6-methyl-1H,4H,5H-pyrrolo[3,2-c]pyridin-4-one, 98%, 1g

4-Bromo-3-methylphenyl 2,2,2-trifluoroacetate, 1g

4,4'-Dihydroxybenzophenone>98.0%(GC)(T)25g

Solution standard ICP de silicium, ROTI®Star, 1000 mg/l Si, densité (D) 1,002 g/cm³

tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)piperazine-1-carboxylate, 95.0%, 100g

3-((4-METHYLPIPERAZIN-1-YL)METHYL)-5-(TRIFLUOROMETHYL)ANILINE, 95.0%, 250mg

Pyrrolidine, 2-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]diphenylmethyl]-, (2R)-, 98%, 1g